Can inhaled cell vesicles soothe damaged lungs in autoimmune disease?
Disease control
Not yet recruiting
This early-phase trial tests a nebulized therapy called UC-EVs, derived from human umbilical cord cells, in adults with immune-mediated inflammatory diseases (such as IgG4-related disease or systemic sclerosis) that affect the lungs. Participants inhale the vesicles daily for 7 d…
Early phase 1 • Sponsor: Qiubai Li • Aim: Disease control
Last updated Sep 09, 2026 18:00 UTC